Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making
- 1 December 2000
- Vol. 56 (6) , 1021-1024
- https://doi.org/10.1016/s0090-4295(00)00793-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- FAILURE TO ACHIEVE CASTRATE LEVELS OF TESTOSTERONE DURING LUTEINIZING HORMONE RELEASING HORMONE AGONIST THERAPY: THE CASE FOR MONITORING SERUM TESTOSTERONE AND A TREATMENT DECISION ALGORITHMJournal of Urology, 2000
- Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate CancerNew England Journal of Medicine, 1998
- Goserelin versus orchiectomy in the treatment of advanced prostate cancer: Final results of a randomized trialUrology, 1995
- Effect of Orchidectomy on Serum Concentrations of Testosterone and Dihydrotestosterone in Patients with Prostatic CancerScandinavian Journal of Urology and Nephrology, 1992
- Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic CarcinomaBritish Journal of Urology, 1991
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic CancerBritish Journal of Urology, 1973
- Testosterone in Human PlasmaNew England Journal of Medicine, 1965
- Determination of Testosterone in Human Peripheral and Adrenal Venous PlasmaJournal of Clinical Endocrinology & Metabolism, 1964
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941